About Southern Maine Health Care
Clinical Trials at Southern Maine Health Care
During the past decade, Southern Maine Health Care conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Southern Maine Health Care" #1 sponsor was "Amgen" with 1 trials, followed by "Boehringer Ingelheim" with 1 trials
sponsored, "Brigham and Women's Hospital" with 1 trials sponsored, "Ipsen" with 1 trials sponsored and "Kowa Research Institute, Inc."
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Maine Health Care"
#1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Southern Maine Health Care
According to Clinical.Site data, the most researched conditions in "Southern Maine Health Care" are
"Arthritis, Rheumatoid" (1 trials), "Atrial Fibrillation" (1 trials), "Cardiovascular Disease" (1 trials), "Coronary Heart Disease (CHD)" (1 trials) and "Dyslipidemia" (1 trials). Many other conditions were trialed in "Southern Maine Health Care" in a lesser frequency.
Clinical Trials Intervention Types at Southern Maine Health Care
Most popular intervention types in "Southern Maine Health Care" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Bococizumab (PF-04950615; RN316)" (1 trials), "Evolocumab" (1 trials), "Ibuprofen" (1 trials) and "Irinotecan liposome injection" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Southern Maine Health Care
The vast majority of trials in "Southern Maine Health Care" are
7 trials for "All" genders.
Clinical Trials Status at Southern Maine Health Care
Currently, there are NaN active trials in "Southern Maine Health Care".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Southern Maine Health Care,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Southern Maine Health Care, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".